VIR_logo_large.jpg
Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference
February 28, 2023 16:05 ET | Vir Biotechnology, Inc.
SAN FRANCISCO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Bolyn Hubby, Ph.D., Executive Vice President and Chief Corporate Affairs Officer, will...
Prometheus_Biosciences_Logo.jpg
Prometheus Biosciences to Participate at the Cowen 42nd Annual Healthcare Conference
March 01, 2022 08:30 ET | Prometheus Biosciences
SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
logo color s and clearside.jpg
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2022
March 01, 2022 07:05 ET | Clearside Biomedical, Inc.
ALPHARETTA, Ga., March 01, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through...
Apellis logo.jpg
Apellis Pharmaceuticals to Present at the Cowen 39th Annual Health Care Conference
March 04, 2019 16:00 ET | Apellis Pharmaceuticals, Inc.
WALTHAM Mass. and CRESTWOOD, Ky., March 04, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel...
KINIKSA _2c_final - Copy.jpg
Kiniksa Pharmaceuticals to Present at the Cowen and Company 39th Annual Healthcare Conference
February 28, 2019 07:30 ET | Kiniksa Pharmaceuticals, Ltd.
HAMILTON, Bermuda, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the Cowen and Company 39th Annual Healthcare Conference on...
Apellis logo.jpg
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
February 23, 2018 07:00 ET | Apellis Pharmaceuticals, Inc.
CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company developing a platform of novel...